• トップページ
  • 診療のご案内
  • センターのご紹介
  • 当施設について
  • 診療関連部門診療科のご案内
  • 採用案内

埼玉県立がんセンター > 論文リスト > 2018年度の論文リスト

ここから本文です。

 

掲載日:2019年6月14日

2018年度の論文リスト

 各年度の論文リスト

 ※ボタンをクリックすると年度ごとに一覧を参照できます

2018年度の論文リスト

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Int J Clin Oncol. 2018 Oct;23(5):965-973. doi: 10.1007/s10147-018-1281-8.


EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Li Z* Takenobu H* Setyawati AN, Akita N, Haruta M, Satoh S, Shinno Y, Chikaraishi K, Mukae K, Akter J, Sugino RP, Nakazawa A, Nakagawara A, Aburatani H, Ohira M, Kamijo T. (* contributed equally)
Oncogene. 2018 May;37(20):2714-2727. doi: 10.1038/s41388-018-0133-3.

Aryl hydrocarbon receptor controls adhesion and migration of colon cancer cells.
Ikuta T, Okabe-Kado J
British Journal of Cancer Research 2018; 1(3): 10X- 1xx . doi: 10.31488/bjcr.113

Sweepstake evolution revealed by population-genetic analysis of copy-number alterations in single genomes of breast cancer.
Kato M, Vasco DA, Sugino R, Narushima D, Krasnitz A
R Soc Open Sci. 2017 4(9):171060. doi: 10.1098/rsos.171060.

Amphiregulin-Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis.
Morimoto Y, Hirahara K, Kiuchi M, Wada T, Ichikawa T, Kanno T, Okano M, Kokubo K, Onodera A, Sakurai D, Okamoto Y, Nakayama T.
Immunity. 2018 49(1):134-150.e6. doi: 10.1016/j.immuni.2018.04.023.

Clinical significance of the 2016 WHO classification in Japanese patients with glioma.
Iuchi T, Sugiyama T, Ohira M, Kageyama H, Yokoi S, Sakaida T, Hasegawa Y, Setoguchi T, Itami M.
Brain Tumor Pathol. 2018 35:71-80. doi:10.1007/s10014-018-0309-0.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K.
J Natl Cancer Inst. 2018 110:1084-1093. doi: 10.1093/jnci/djy022.

Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
Koshinaga T, Takimoto T, Oue T, Okita H, Tanaka Y, Nozaki M, Tsuchiya K, Inoue E, Haruta M, Kaneko Y, Fukuzawa M.
Pediatr Blood Cancer. 2018 65:e27056. doi: 10.1002/pbc.27056.

Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
Sato Y, Haruta M, Kaneko Y, Nakasato Y, Kurosawa H, Yoshihara S.
Pediatr Blood Cancer. 2018 16: e27442. DOI: 10.1002/pbc.27442

Comparing protein and mRNA expressions of the human epidermal growth factor
receptor family in estrogen receptor-positive breast cancer.
Kurozumi S, Yamaguchi Y, Matsumoto H, Inoue K, Kurosumi M, Oyama T, Horiguchi J, Fujii T, Shirabe K.
Med Mol Morphol. 2018 Sep 27. doi: 10.1007/s00795-018-0206-y.

Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer.
Kimura M, Hanamura T, Tsuboi K, Kaneko Y, Yamaguchi Y, Niwa T, Narui K, Endo I, Hayashi S.
Oncotarget 2018 9: 21468-21477. doi: 10.18632/oncotarget.25133

NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.
Okabe-Kado J, Hagiwara-Watanabe Y, Niitsu N, Kasukabe T, Kaneko Y.
Leuk Res. 2018; 66:39-48. DOI: 10.1016/j.leukres.2018.01.003

Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses.
Takada K, Amano R, Nomura Y, Tanaka Y, Sugiyama S, Nagata T, Katahira M, Nakamura Y, Kozu T, Sakamoto T.
FEBS Open Bio. 2018 8:264-270. DOI: 10.1002/2211-5463.12368

Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth.
Rawangkan A, Wongsirisin P, Namiki K, Iida K, Kobayashi Y, Shimizu Y, Fujiki H, Suganuma M.
Molecules 2018 23(8): 2071. DOI: 10.3390/molecules23082071

オカダ酸の多様な機能「天然物の化学II 自然からの贈り物」
菅沼雅美, 藤木博太, 上村大輔編 
東京化学同人、化学のとびら64、2018

 

お問い合わせ

病院局 がんセンター  

郵便番号362-0806 埼玉県北足立郡伊奈町小室780番地 埼玉県立がんセンター

ファックス:048-722-1129

より良いウェブサイトにするためにみなさまのご意見をお聞かせください

このページの情報は役に立ちましたか?

このページの情報は見つけやすかったですか?